Cargando…
Glucose-Insulin Therapy, Plasma Substrate Levels and Cardiac Recovery After Cardiac Ischemic Events
INTRODUCTION: The potential usefulness of glucose-insulin therapy relies to a large extent on the premise that it prevents hyperglycemia and hyperlipidemia following cardiac ischemic events. METHODS: In this review we evaluate the literature concerning plasma glucose and free fatty acids levels duri...
Autores principales: | Zuurbier, C. J., Van Wezel, H. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2329728/ https://www.ncbi.nlm.nih.gov/pubmed/18266096 http://dx.doi.org/10.1007/s10557-008-6087-x |
Ejemplares similares
-
Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?
por: Zuurbier, Coert J.
Publicado: (2020) -
Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017) -
Association between Preoperative Plasma sRAGE Levels and Recovery from Cardiac Surgery
por: Creagh-Brown, Benedict C., et al.
Publicado: (2013) -
High‐Sensitivity Cardiac Troponin T and Recurrent Vascular Events After First Ischemic Stroke
por: Scheitz, Jan F., et al.
Publicado: (2021) -
Plasma Levels of Glucose and Insulin in Patients with Brain Tumors
por: ALEXANDRU, OANA, et al.
Publicado: (2014)